Delft-based Sensible Healthcare Systems, a company specialised in developing next-generation continuous biosensor platforms, announced the closing of a pre-seed funding round. However, the company didn’t disclose the exact funding figures.
The financing comes from a group of expert investors including Glass Frog Ventures and the Graduate Entrepreneur Fund.
Notably, one of the investors, Mart Snoek, will also join the management team as an expert in diabetes care and technology.
The Dutch company says it will use the funds to further develop and bring to market Sensible’s minimally-invasive continuous biosensing platform.